Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.. Founded in 2018, Monte Rosa Therapeutics is backed by investors that include New Enterprise Associates (NEA) and Versant Ventures and is headquartered in Basel.
FOUNDED:
2018
INDUSTRY:
Biotechnology, Therapeutics
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
